ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IBRX ImmunityBio, Inc.

交易中 11-22 10:30:15 EST

4.92

-0.11

-2.28%

最高5.07	最低4.91	成交量55.05万
今开5.05	昨收5.04	日振幅3.17%
总市值34.28亿	流通市值8.16亿	总股本6.97亿
成交额273.98万	换手率0.33%	流通股本1.66亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IBRX","market":"US","secType":"STK","nameCN":"ImmunityBio, Inc.","latestPrice":4.92,"timestamp":1732289413938,"preClose":5.035,"halted":0,"volume":550522,"delay":0,"floatShares":165766827,"shares":696831296,"eps":-0.877402,"marketStatus":"交易中","marketStatusCode":2,"change":-0.115,"latestTime":"11-22 10:30:15 EST","open":5.05,"high":5.07,"low":4.9102,"amount":2739765.9363746,"amplitude":0.031738,"askPrice":4.92,"askSize":1516,"bidPrice":4.91,"bidSize":5047,"shortable":3,"etf":0,"ttmEps":-0.877402,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"listingDate":1438056000000,"adjPreClose":5.035,"preHourTrading":{"tag":"盘前","latestPrice":5.054,"preClose":5.035,"latestTime":"09:28 EST","volume":29562,"amount":150706.1181912,"timestamp":1732285729994},"postHourTrading":{"tag":"盘后","latestPrice":5.1,"preClose":5.035,"latestTime":"19:38 EST","volume":60672,"amount":305691.5855,"timestamp":1732235899890},"volumeRatio":0.784192,"impliedVol":0.9843,"impliedVolPercentile":0.2937},"requestUrl":"/m/hq/s/IBRX","defaultTab":"news","newsList":[{"id":"2485443658","title":"Immunitybio, Inc.盘中异动 急速上涨5.01%报5.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485443658","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485443658?lang=zh_cn&edition=full","pubTime":"2024-11-22 02:00","pubTimestamp":1732212032,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日02时00分，Immunitybio, Inc.股票出现异动，股价大幅拉升5.01%。截至发稿，该股报5.12美元/股，成交量192.393万股，换手率0.28%，振幅5.68%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122020032abd53df9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122020032abd53df9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2484143048","title":"Immunitybio, Inc.盘中异动 早盘快速下挫5.05%报5.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484143048","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484143048?lang=zh_cn&edition=full","pubTime":"2024-11-20 23:07","pubTimestamp":1732115244,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日23时07分，Immunitybio, Inc.股票出现异动，股价快速下挫5.05%。截至发稿，该股报5.08美元/股，成交量63.7562万股，换手率0.09%，振幅4.86%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120230724971a7b5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120230724971a7b5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"1172442031","title":"异动解读 | Immunitybio, Inc.盘中大涨5.19%,业绩向好或是主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1172442031","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172442031?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:04","pubTimestamp":1732028665,"startTime":"0","endTime":"0","summary":"Immunitybio, Inc.今日盘中股价大涨5.19%,引发市场广泛关注。根据相关新闻报道显示,公司2024财年第三财季净利润虽然为负值,但同比增长10.31%,营业收入6.11百万美元更是同比大增7351.22%,这或是导致该股大涨的主要原因之一。另外,公司最新财报数据显示,其资产负债比为0.33,流动比率为0.03,短期偿债能力有待加强。作为一家生物技术公司,Immunitybio主攻免疫和细胞疗法,目前主要产品包括膀胱癌、肺癌等重大疾病领域,市场空间广阔。上述正面因素的影响下,该股盘中出现大涨表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Immunitybio, Inc.盘中大涨5.19%,业绩向好或是主因","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["IBRX"],"gpt_icon":0},{"id":"2484928284","title":"Immunitybio, Inc.盘中异动 早盘大幅上涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484928284","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484928284?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:39","pubTimestamp":1732027198,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时39分，Immunitybio, Inc.股票出现波动，股价快速上涨5.09%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922395998e43826&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922395998e43826&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2484915368","title":"Immunitybio, Inc.2024财年第三财季实现净利润-85.73百万美元，同比增加10.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484915368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484915368?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010415,"startTime":"0","endTime":"0","summary":"11月19日，Immunitybio, Inc.公布财报，公告显示公司2024财年第三财季净利润为-85.73百万美元，同比增加10.31%；其中营业收入为6.11百万美元，同比增加7351.22%，每股基本收益为-0.12美元。从资产负债表来看，Immunitybio, Inc.总负债11.09亿美元，其中短期债务9.20百万美元，资产负债比为0.33，流动比率为0.03。机构评级：截至2024年11月19日，当前有3家机构对Immunitybio, Inc.目标价做出预测，其中目标均价为14.25美元，其中最低目标价为4.75美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180022a24561a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180022a24561a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX"],"gpt_icon":0},{"id":"2484672170","title":"Immunitybio, Inc.盘中异动 大幅上涨5.01%报4.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484672170","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484672170?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:35","pubTimestamp":1731944101,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时35分，Immunitybio, Inc.股票出现波动，股价快速上涨5.01%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118233502971a7383&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118233502971a7383&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2483533118","title":"Immunitybio, Inc.盘中异动 股价大涨5.07%报5.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483533118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483533118?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:19","pubTimestamp":1731615577,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时19分，Immunitybio, Inc.股票出现波动，股价急速上涨5.07%。截至发稿，该股报5.08美元/股，成交量387.078万股，换手率0.56%，振幅8.70%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为1.38%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115041937971a6a1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115041937971a6a1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2482008447","title":"免疫生物公司报告本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2482008447","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482008447?lang=zh_cn&edition=full","pubTime":"2024-11-12 23:29","pubTimestamp":1731425393,"startTime":"0","endTime":"0","summary":"免疫生物公司报告本季度业绩 - 收益摘要Immunitybio Inc IBRX.OQ报告本季度调整后每股亏损12美分，高于去年同期的每股-19美分。三位分析师对该季度的平均预期是每股亏损 18 美分。华尔街预期为每股-19 美分至-17 美分。该公司一季度亏损8573万美元。Immunitybio Inc股价本季度上涨了46.5%，今年迄今为止上涨了8.6%。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nL4S3MJ1Q0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2482738901","title":"Immunitybio, Inc.盘中异动 股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738901","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738901?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:31","pubTimestamp":1731335478,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时31分，Immunitybio, Inc.股票出现波动，股价快速拉升5.23%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122312398e41c40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122312398e41c40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2480584721","title":"Immunitybio, Inc.盘中异动 早盘急速下挫5.87%报4.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480584721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480584721?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:52","pubTimestamp":1730731979,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时52分，Immunitybio, Inc.股票出现波动，股价大幅下跌5.87%。截至发稿，该股报4.97美元/股，成交量52.3645万股，换手率0.08%，振幅4.55%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225259a215534f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225259a215534f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":1},{"id":"2479783730","title":"Immunitybio, Inc.盘中异动 快速跳水5.17%报5.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479783730","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479783730?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:31","pubTimestamp":1730295107,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时31分，Immunitybio, Inc.股票出现异动，股价急速下跌5.17%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021314798e3f65c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021314798e3f65c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":1},{"id":"2479037288","title":"Immunitybio, Inc.盘中异动 早盘快速下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479037288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479037288?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:45","pubTimestamp":1730209508,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时45分，Immunitybio, Inc.股票出现波动，股价快速跳水5.02%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921450898e3f1be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921450898e3f1be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":1},{"id":"2478481623","title":"Immunitybio, Inc.盘中异动 快速拉升7.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478481623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478481623?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:31","pubTimestamp":1730122281,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时31分，Immunitybio, Inc.股票出现异动，股价快速上涨7.89%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821312195bd74f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821312195bd74f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2478933523","title":"Immunitybio, Inc.盘中异动 早盘股价大涨15.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478933523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478933523?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:31","pubTimestamp":1729863063,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时31分，Immunitybio, Inc.股票出现波动，股价快速上涨15.07%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521310395bd5899&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521310395bd5899&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELAB","BK4183","IBRX","BK4139"],"gpt_icon":0},{"id":"2477632388","title":"Immunitybio, Inc.盘中异动 早盘快速上涨5.78%报3.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477632388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477632388?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:57","pubTimestamp":1729778256,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时57分，Immunitybio, Inc.股票出现波动，股价大幅上涨5.78%。截至发稿，该股报3.66美元/股，成交量50.9万股，换手率0.07%，振幅5.20%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024215736971a213c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024215736971a213c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2477382155","title":"Immunitybio, Inc.盘中异动 早盘急速上涨5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477382155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477382155?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:31","pubTimestamp":1729690270,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时31分，Immunitybio, Inc.股票出现波动，股价大幅拉升5.87%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023213110a1e3fed3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023213110a1e3fed3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2476486619","title":"Immunitybio, Inc.盘中异动 下午盘急速下跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476486619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476486619?lang=zh_cn&edition=full","pubTime":"2024-10-18 01:52","pubTimestamp":1729187540,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日01时52分，Immunitybio, Inc.股票出现异动，股价急速下跌5.26%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为1.05%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018015220971a0e4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018015220971a0e4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2474222312","title":"Immunitybio, Inc.盘中异动 早盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474222312","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474222312?lang=zh_cn&edition=full","pubTime":"2024-10-09 22:33","pubTimestamp":1728484437,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日22时33分，Immunitybio, Inc.股票出现波动，股价大幅跳水5.11%。截至发稿，该股报3.34美元/股，成交量59.0825万股，换手率0.08%，振幅5.11%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009223357a1df6e38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009223357a1df6e38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","IBRX","BK4139"],"gpt_icon":0},{"id":"2472990641","title":"Immunitybio, Inc.盘中异动 下午盘急速下挫5.04%报3.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472990641","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472990641?lang=zh_cn&edition=full","pubTime":"2024-10-04 01:30","pubTimestamp":1727976656,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日01时30分，Immunitybio, Inc.股票出现波动，股价快速下挫5.04%。截至发稿，该股报3.39美元/股，成交量119.272万股，换手率0.17%，振幅3.78%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为1.50%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100401305698e3a749&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100401305698e3a749&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELAB","IBRX","BK4139","BK4183"],"gpt_icon":0},{"id":"2472553293","title":"Immunitybio, Inc.盘中异动 下午盘股价大跌5.09%报3.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472553293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472553293?lang=zh_cn&edition=full","pubTime":"2024-10-01 03:28","pubTimestamp":1727724513,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日03时28分，Immunitybio, Inc.股票出现异动，股价大幅跳水5.09%。截至发稿，该股报3.73美元/股，成交量163.297万股，换手率0.23%，振幅5.00%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001032834ab67327e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001032834ab67327e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunitybio.com","stockEarnings":[{"period":"1week","weight":0.0339},{"period":"1month","weight":0.4427},{"period":"3month","weight":0.1847},{"period":"6month","weight":-0.2278},{"period":"1year","weight":0.2017},{"period":"ytd","weight":0.003}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ImmunityBio, Inc.于2002年10月7日在伊利诺伊州ZelleRx Corporation公司的名义下注册成立，于2010年1月22日，公司更名为Conkwest股份有限公司。ImmunityBio是一家领先的后期免疫疗法公司，可激活先天性（NK细胞和巨噬细胞）和适应性（T细胞）免疫系统，以治疗肿瘤学和传染病中严重的未满足需求。他们是现成的自然杀伤（NK）细胞疗法，自体/同种异体记忆NK细胞（m-ceNK）的临床剂型的领先生产商，以及抗体细胞因子融合蛋白，白蛋白结合化学疗法的全面平台免疫调节剂和疫苗载体。通过组合这些NK，巨噬细胞和T细胞活化平台，他们相信ImmunityBio引领免疫疗法领域，跨多种肿瘤类型和感染性疾病进行后期临床开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":-0.010395},{"month":2,"riseRate":0.555556,"avgChangeRate":0.03495},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.083743},{"month":4,"riseRate":0.555556,"avgChangeRate":0.042504},{"month":5,"riseRate":0.333333,"avgChangeRate":0.053418},{"month":6,"riseRate":0.333333,"avgChangeRate":0.147898},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.024912},{"month":8,"riseRate":0.3,"avgChangeRate":-0.116269},{"month":9,"riseRate":0.3,"avgChangeRate":-0.041956},{"month":10,"riseRate":0.5,"avgChangeRate":0.035321},{"month":11,"riseRate":0.7,"avgChangeRate":0.135624},{"month":12,"riseRate":0.444444,"avgChangeRate":0.132393}],"exchange":"NASDAQ","name":"ImmunityBio, Inc.","nameEN":"ImmunityBio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ImmunityBio, Inc.(IBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ImmunityBio, Inc.,IBRX,ImmunityBio, Inc.股票,ImmunityBio, Inc.股票老虎,ImmunityBio, Inc.股票老虎国际,ImmunityBio, Inc.行情,ImmunityBio, Inc.股票行情,ImmunityBio, Inc.股价,ImmunityBio, Inc.股市,ImmunityBio, Inc.股票价格,ImmunityBio, Inc.股票交易,ImmunityBio, Inc.股票购买,ImmunityBio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ImmunityBio, Inc.(IBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}